2021 NOSCM | Chimeric Antigen Receptor T-Cell Therapy: Indications and Remaining Challenges
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Mohamed Kharfan-Dabaja, MD
Disclosure
Mohamed Kharfan-Dabaja, MD discloses no such relationships exist
Accreditation
NA
Related Courses
-1769183671548.webp&w=3840&q=75)
2026 MCM | Dealing with Long Term Effects of Breast Cancer Immunotherapy and Targeted Therapy
0.00 AMA PRA Category 1 Credits™
1 Chapter
Immunotherapy
Free
-1769183559393.webp&w=3840&q=75)
2026 MCM | Integrative Medicine and Cancer: How to Improve the Quality of Life and Well Being of Our Patients and Survivors
0.00 AMA PRA Category 1 Credits™
1 Chapter
Immunotherapy
Free